Format
Sort by

Send to

Choose Destination

Search results

Items: 17

1.

Lessons Learned and Questions Raised by an Atypical Case of Clozapine-Induced Myocarditis.

Earnshaw CH, Powell L, Haeney O.

Case Rep Psychiatry. 2016;2016:4159081. doi: 10.1155/2016/4159081. Epub 2016 Jul 5.

2.

Observational infant exploratory [(14)C]-paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis.

Garner CR, Park KB, French NS, Earnshaw C, Schipani A, Selby AM, Byrne L, Siner S, Crawley FP, Vaes WH, van Duijn E, deLigt R, Varendi H, Lass J, Grynkiewicz G, Maruszak W, Turner MA.

Br J Clin Pharmacol. 2015 Jul;80(1):157-67. doi: 10.1111/bcp.12597. Epub 2015 Jun 1.

3.

Mass spectrometric characterization of circulating covalent protein adducts derived from a drug acyl glucuronide metabolite: multiple albumin adductions in diclofenac patients.

Hammond TG, Meng X, Jenkins RE, Maggs JL, Castelazo AS, Regan SL, Bennett SN, Earnshaw CJ, Aithal GP, Pande I, Kenna JG, Stachulski AV, Park BK, Williams DP.

J Pharmacol Exp Ther. 2014 Aug;350(2):387-402. doi: 10.1124/jpet.114.215079. Epub 2014 Jun 5.

4.

Hedgehog signaling controls T cell killing at the immunological synapse.

de la Roche M, Ritter AT, Angus KL, Dinsmore C, Earnshaw CH, Reiter JF, Griffiths GM.

Science. 2013 Dec 6;342(6163):1247-50. doi: 10.1126/science.1244689.

5.

T cell responses to drugs and drug metabolites.

Earnshaw CJ, Pecaric-Petkovic T, Park BK, Naisbitt DJ.

EXS. 2014;104:137-63. doi: 10.1007/978-3-0348-0726-5_10. Review.

PMID:
24214623
6.

Detection of drug bioactivation in vivo: mechanism of nevirapine-albumin conjugate formation in patients.

Meng X, Howarth A, Earnshaw CJ, Jenkins RE, French NS, Back DJ, Naisbitt DJ, Park BK.

Chem Res Toxicol. 2013 Apr 15;26(4):575-83. doi: 10.1021/tx4000107. Epub 2013 Mar 12.

PMID:
23448204
7.

Starting to smoke: a qualitative study of the experiences of Australian indigenous youth.

Johnston V, Westphal DW, Earnshaw C, Thomas DP.

BMC Public Health. 2012 Nov 10;12:963. doi: 10.1186/1471-2458-12-963.

8.

Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury.

Monshi MM, Faulkner L, Gibson A, Jenkins RE, Farrell J, Earnshaw CJ, Alfirevic A, Cederbrant K, Daly AK, French N, Pirmohamed M, Park BK, Naisbitt DJ.

Hepatology. 2013 Feb;57(2):727-39. doi: 10.1002/hep.26077.

PMID:
22987284
9.

The speed of sound and attenuation of an IEC agar-based tissue-mimicking material for high frequency ultrasound applications.

Sun C, Pye SD, Browne JE, Janeczko A, Ellis B, Butler MB, Sboros V, Thomson AJ, Brewin MP, Earnshaw CH, Moran CM.

Ultrasound Med Biol. 2012 Jul;38(7):1262-70. doi: 10.1016/j.ultrasmedbio.2012.02.030. Epub 2012 Apr 12.

10.

Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis.

Whitaker P, Meng X, Lavergne SN, El-Ghaiesh S, Monshi M, Earnshaw C, Peckham D, Gooi J, Conway S, Pirmohamed M, Jenkins RE, Naisbitt DJ, Park BK.

J Immunol. 2011 Jul 1;187(1):200-11. doi: 10.4049/jimmunol.1100647. Epub 2011 May 23.

11.

Direct analysis of pharmaceutical tablet formulations using Matrix-Assisted Laser Desorption/Ionisation Mass Spectrometry Imaging.

Earnshaw CJ, Carolan VA, Richards DS, Clench MR.

Rapid Commun Mass Spectrom. 2010 Jun 15;24(11):1665-72. doi: 10.1002/rcm.4525.

PMID:
20486264
12.

Synthesis and SAR of novel 2-arylthiazolidinones as selective analgesic N-type calcium channel blockers.

Knutsen LJ, Hobbs CJ, Earnshaw CG, Fiumana A, Gilbert J, Mellor SL, Radford F, Smith NJ, Birch PJ, Russell Burley J, Ward SD, James IF.

Bioorg Med Chem Lett. 2007 Feb 1;17(3):662-7. Epub 2006 Nov 6.

PMID:
17134896
14.

Design and synthesis of inhibitors of adenosine and AMP deaminases.

Bojack G, Earnshaw CG, Klein R, Lindell SD, Lowinski C, Preuss R.

Org Lett. 2001 Mar 22;3(6):839-42.

PMID:
11263895
15.

The design and synthesis of inhibitors of adenosine 5'-monophosphate deaminase.

Lindell SD, Moloney BA, Hewitt BD, Earnshaw CG, Dudfield PJ, Dancer JE.

Bioorg Med Chem Lett. 1999 Jul 19;9(14):1985-90.

PMID:
10450967
16.

Computer prediction of possible toxic action from chemical structure: an update on the DEREK system.

Ridings JE, Barratt MD, Cary R, Earnshaw CG, Eggington CE, Ellis MK, Judson PN, Langowski JJ, Marchant CA, Payne MP, Watson WP, Yih TD.

Toxicology. 1996 Jan 8;106(1-3):267-79.

PMID:
8571398
17.

Computer prediction of possible toxic action from chemical structure; the DEREK system.

Sanderson DM, Earnshaw CG.

Hum Exp Toxicol. 1991 Jul;10(4):261-73.

PMID:
1679649
Items per page

Supplemental Content

Loading ...
Write to the Help Desk